A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers
Clinical trial NCT04451811 · COMPLETED
Trial details
- NCT number
- NCT04451811
- Sponsor
- Oppilan Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2021-02-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.